Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The Company conducted sales activities targeting facilities through its 30 branches and sales offices nationwide. There were 182 new contracts and 70 cancellations, and the number of facilities adopting the CS Set service increased by 112 from the end of the previous fiscal year to 2,942.
No applicable matters ("There are no applicable matters")
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥29,525 million (YoY +10.0%) |
| Operating profit | ¥2,641 million (YoY +28.3%) |
| Ordinary income | ¥2,591 million (YoY +27.5%) |
| Profit attributable to owners of the parent | ¥1,738 million (YoY +27.2%) |
| Net income per share | ¥28.74 |
| Equity ratio | End of the current fiscal period 56.5 / End of previous period 54.3 |
| Total assets | ¥27,148 million |
| Net assets | ¥15,770 million |
| Cash flows from operating activities | ¥1,845,878 thousand |
| Cash flows from investing activities | ¥-373,236 thousand |
| Cash flows from financing activities | ¥-947,721 thousand |
| Cash and cash equivalents at end of period | ¥7,359,116 thousand |
| Full-year earnings forecast | Net Sales ¥60,800 million (YoY +9.7%) / Operating profit ¥5,000 million (YoY +17.0%) / Ordinary income ¥5,000 million (YoY +19.5%) / Net income ¥3,200 million (YoY +15.6%) |
| Revision to Earnings Forecast | Net Sales No revision / Operating profit No revision / Ordinary income No revision / Net income No revision |
| Annual Dividend Forecast | ¥15 → ¥16 |
| Depreciation and amortization | ¥146,509 thousand |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 60,600,000 shares |
| Treasury Shares at Period-End | 114,047 shares |
| Factors Behind Changes in Business Performance | The Company conducted sales activities targeting facilities through its 30 branches and sales offices nationwide. There were 182 new contracts and 70 cancellations, and the number of facilities adopting the CS Set service increased by 112 from the end of the previous fiscal year to 2,942. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company conducted sales activities targeting hospitals, geriatric health services facilities and other institutions through its 30 branches and sales offices nationwide. As a result, there were 182 new contracts and 70 cancellations, increasing the number of facilities adopting the CS Set service by 112 from the end of the previous fiscal year to 2,942.